Navigation Links
Dr. Neal Rouzier Joins BioTE Medical

DALLAS, July 22, 2014 /PRNewswire/ -- BioTE Medical, a leading provider of hormone replacement therapy using natural, bio-identical hormone pellets, today announced the addition of Dr. Neal Rouzier, MD to the company.   Dr. Rouzier is joining the BioTE Medical Advisory Board as a training physician.     

Dr. Rouzier was residency trained in Family Medicine and Emergency Medicine at UCLA and is a board certified emergency physician still practicing at a large metropolitan trauma center in Southern California.  He is also founder and director of the Preventive Medicine Clinic of Palm Springs where he specializes in optimizing hormones for men and women.  Commenting on the addition of Dr. Rouzier to the BioTE Medical team, BioTE Medical Founder Dr. Gary Donovitz commented, "I've known Dr. Neal Rouzier for years.   His dedication to innovation in the areas of anti-aging and hormone replacement therapy make him a perfect fit with BioTE Medical.  Our growth has been phenomenal in the last 3 years, and with the leadership of people like Dr. Rouzier, we're going to be helping more and more people discover how good life can be when their hormones are balanced."     

Dr. Rouzier stated that he was looking forward to making a contribution to the fast growing BioTE Medical and that he shares Dr. Donovitz's passion for teaching.   He said, "Dr. Donovitz, Dan DeNeui (BioTE COO) and their team have done tremendous work to bring bio-identical hormone replacement to the forefront of people's awareness.   I'm looking forward to helping them bring this innovation to practices in Southern California and other west coast markets.  I'm excited and grateful to be part of BioTE Medical." 

Dan DeNeui, BioTE Medical COO, said the addition of Dr. Rouzier is consistent with BioTE's mission of supporting medical practitioners.  DeNeui, who heads BioTE Medical's monthly training for physicians in Dallas, TX, commented, "The BioTE Method works because it is natural and also because of our training and precision.   Having a person like Dr. Rouzier available for our research and training is invaluable.   His addition underscores our commitment to helping our medical practitioners be successful in all aspects of working with BioTE Medical." 

Dr. Rouzier will also be active in the launching of BioTE Research & Development in 2015.   Dr. Donovitz added, "Dr. Rouzier will be a part of our research & development including the upcoming study regarding the effect of hormone therapy on veterans suffering from Post-Traumatic Stress Disorder (PTSD) and head injuries."

Founded in 2011, BioTE Medical has experienced impressive growth.  Over 600 medical practitioners from 32 states currently offer patients the BioTE method of bio-identical hormone replacement therapy.   Cumulatively, BioTE certified practitioners have treated over 100,000 patients.     

Interviews Available

McQ Media 

Photo -

SOURCE BioTE Medical
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Robert Farrell Joins Bionovos Board of Directors
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
5. First Choice Rehabilitation Specialists Joins Select Medical
6. Excel Life Sciences Joins DATATRAKs Connect Partner Program
7. Marina Biotech, Inc. Joins OTCQX
8. Richard H. Scheuermann, Ph.D. Joins J. Craig Venter Institute as Director of Informatics
9. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
10. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
11. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
Breaking Biology News(10 mins):